+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Pessary Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • PDF Icon

    Report

  • 265 Pages
  • June 2025
  • Region: Global
  • Fairfield Market Research
  • ID: 5916036
The global pessary market is witnessing robust growth due to a significant rise in pelvic organ prolapse (POP) and urinary incontinence cases. A pessary is a non-surgical, intravaginal device designed to support the uterus, bladder, rectum, or vaginal walls in women suffering from POP or incontinence. With advancements in material technology and growing awareness around women’s health, the market is gaining considerable traction.

Market Insights

According to recent market research, the pessary market is anticipated to grow from US$ 430 billion in 2025 to US$ 760 billion by 2032, reflecting a CAGR of 8.48% during the forecast period. A key factor contributing to this expansion is the increasing demand for conservative management options for POP and stress urinary incontinence, especially among the elderly female population.

Ring pessaries, among the various product types available, remain the most widely used due to their ease of insertion, comfort, and ability to cater to different stages of prolapse and incontinence. This product segment continues to dominate due to its compatibility with a large percentage of female anatomies.

Key Drivers

A growing geriatric population worldwide is one of the primary drivers fueling market growth. Aging weakens the pelvic floor muscles, increasing the likelihood of prolapse and related complications. Additionally, lifestyle-associated diseases and multiple pregnancies contribute to pelvic floor disorders among younger women as well.

The preference for non-invasive alternatives over surgical interventions further boosts the adoption of pessaries. Many women, especially those who are physically unfit for surgery or wish to delay surgical correction, are choosing pessaries as their first-line treatment.

The COVID-19 pandemic also emphasized the role of pessaries as a temporary solution when elective surgeries were postponed. This led to greater adoption among patients and increased awareness among clinicians regarding their therapeutic value.

Business Opportunity

The pessary market presents promising opportunities for manufacturers. The development of patient-specific and 3D-printed pessaries offers immense scope for innovation. Companies leveraging technologies such as cloud software, machine learning, and ultrasound to create customized pessary devices are expected to capitalize on this opportunity.

There is also considerable potential in emerging markets where awareness about pelvic organ prolapse is growing. Increasing investments in healthcare infrastructure and women’s health programs in regions such as South Asia and East Asia are anticipated to propel demand further.

Regional Analysis

North America, particularly the United States, remains a significant revenue generator for pessary manufacturers. A high prevalence of POP, growing elderly female population, and advanced healthcare systems contribute to the region’s dominance.

Europe, led by Germany, is witnessing strong demand due to government-backed women’s health initiatives and an increased focus on non-invasive therapeutic options. The country’s healthcare infrastructure and lifestyle patterns also support market growth.

East Asia, with China at the forefront, shows the highest growth potential. China’s aging population and rising incidence of urinary incontinence are key factors boosting demand. Additionally, increased disposable income and better access to healthcare are supporting the uptake of pessary devices.

Key Players

The pessary market is highly fragmented, with numerous global and regional manufacturers competing for market share. Key players operating in the global market include:

  • CooperSurgical Inc.
  • Bliss GVS Pharma
  • MedGyn
  • Panpac Medical Corporation
  • Bioteque America
  • Personal Medical Corporation
  • Dr. Arabin GmbH & Co.
  • Kangge Medical
  • Integra Lifesciences
  • Wallach Surgical Devices
  • Medesign
These companies are focused on strategic collaborations, product launches, and technological innovations to strengthen their market position and expand their global footprint.

Segmentation

By Product:

  • Ring Pessaries
  • Lever Pessaries
  • Incontinence Rings
  • Marland
  • Gellhorn
  • Gehrung
  • Donuts
  • Cubes

By Indication:

  • Pelvic Organ Prolapse
  • Urinary Incontinence

By End User:

  • Hospitals
  • Ambulatory Surgical Centres
  • Speciality Clinics

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East and Africa (MEA)

This product will be delivered within 1-3 business days.

Table of Contents

1. Executive Summary
1.1. Global Pessary Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value and Volume, 2025
1.5. Analyst Recommendations
2. Market Overview
2.1. Market Definitions and Segmentations
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter’s Five Forces Analysis
2.5. COVID-19 Impact Analysis
2.5.1. Supply
2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
2.7.1. World Economic Projections
2.8. PESTLE Analysis
3. Global Pessary Market Outlook, 2019-2032
3.1. Global Pessary Market Outlook, by Product, Value (US$ Mn), 2019-2032
3.1.1. Key Highlights
3.1.1.1. Ring Pessaries
3.1.1.2. Lever Pessaries
3.1.1.3. Incontinence Rings
3.1.1.4. Marland
3.1.1.5. Gellhorn
3.1.1.6. Gehrung
3.1.1.7. Donuts
3.1.1.8. Cubes
3.2. Global Pessary Market Outlook, by Indication, Value (US$ Mn), 2019-2032
3.2.1. Key Highlights
3.2.1.1. Pelvic Organ Prolapse
3.2.1.2. Urinary Incontinences
3.3. Global Pessary Market Outlook, by End User, Value (US$ Mn), 2019-2032
3.3.1. Key Highlights
3.3.1.1. Hospitals
3.3.1.2. Ambulatory Surgical Centres
3.3.1.3. Speciality Clinics
3.4. Global Pessary Market Outlook, by Region, Value (US$ Mn), 2019-2032
3.4.1. Key Highlights
3.4.1.1. North America
3.4.1.2. Europe
3.4.1.3. Asia Pacific
3.4.1.4. Latin America
3.4.1.5. Middle East & Africa
4. North America Pessary Market Outlook, 2019-2032
4.1. North America Pessary Market Outlook, by Product, Value (US$ Mn), 2019-2032
4.1.1. Key Highlights
4.1.1.1. Ring Pessaries
4.1.1.2. Lever Pessaries
4.1.1.3. Incontinence Rings
4.1.1.4. Marland
4.1.1.5. Gellhorn
4.1.1.6. Gehrung
4.1.1.7. Donuts
4.1.1.8. Cubes
4.2. North America Pessary Market Outlook, by Indication, Value (US$ Mn), 2019-2032
4.2.1. Key Highlights
4.2.1.1. Pelvic Organ Prolapse
4.2.1.2. Urinary Incontinences
4.3. North America Pessary Market Outlook, by End User, Value (US$ Mn), 2019-2032
4.3.1. Key Highlights
4.3.1.1. Hospitals
4.3.1.2. Ambulatory Surgical Centres
4.3.1.3. Speciality Clinics
4.3.2. BPS Analysis/Market Attractiveness Analysis
4.4. North America Pessary Market Outlook, by Country, Value (US$ Mn), 2019-2032
4.4.1. Key Highlights
4.4.1.1. U.S. Pessary Market by Product, Value (US$ Mn), 2019-2032
4.4.1.2. U.S. Pessary Market by Indication, Value (US$ Mn), 2019-2032
4.4.1.3. U.S. Pessary Market by End User, Value (US$ Mn), 2019-2032
4.4.1.4. Canada Pessary Market by Product, Value (US$ Mn), 2019-2032
4.4.1.5. Canada Pessary Market by Indication, Value (US$ Mn), 2019-2032
4.4.1.6. Canada Pessary Market by End User, Value (US$ Mn), 2019-2032
4.4.2. BPS Analysis/Market Attractiveness Analysis
5. Europe Pessary Market Outlook, 2019-2032
5.1. Europe Pessary Market Outlook, by Product, Value (US$ Mn), 2019-2032
5.1.1. Key Highlights
5.1.1.1. Ring Pessaries
5.1.1.2. Lever Pessaries
5.1.1.3. Incontinence Rings
5.1.1.4. Marland
5.1.1.5. Gellhorn
5.1.1.6. Gehrung
5.1.1.7. Donuts
5.1.1.8. Cubes
5.2. Europe Pessary Market Outlook, by Indication, Value (US$ Mn), 2019-2032
5.2.1. Key Highlights
5.2.1.1. Pelvic Organ Prolapse
5.2.1.2. Urinary Incontinences
5.3. Europe Pessary Market Outlook, by End User, Value (US$ Mn), 2019-2032
5.3.1. Key Highlights
5.3.1.1. Hospitals
5.3.1.2. Ambulatory Surgical Centres
5.3.1.3. Speciality Clinics
5.3.2. BPS Analysis/Market Attractiveness Analysis
5.4. Europe Pessary Market Outlook, by Country, Value (US$ Mn), 2019-2032
5.4.1. Key Highlights
5.4.1.1. Germany Pessary Market by Product, Value (US$ Mn), 2019-2032
5.4.1.2. Germany Pessary Market by Indication, Value (US$ Mn), 2019-2032
5.4.1.3. Germany Pessary Market by End User, Value (US$ Mn), 2019-2032
5.4.1.4. U.K. Pessary Market by Product, Value (US$ Mn), 2019-2032
5.4.1.5. U.K. Pessary Market by Indication, Value (US$ Mn), 2019-2032
5.4.1.6. U.K. Pessary Market by End User, Value (US$ Mn), 2019-2032
5.4.1.7. France Pessary Market by Product, Value (US$ Mn), 2019-2032
5.4.1.8. France Pessary Market by Indication, Value (US$ Mn), 2019-2032
5.4.1.9. France Pessary Market by End User, Value (US$ Mn), 2019-2032
5.4.1.10. Italy Pessary Market by Product, Value (US$ Mn), 2019-2032
5.4.1.11. Italy Pessary Market by Indication, Value (US$ Mn), 2019-2032
5.4.1.12. Italy Pessary Market by End User, Value (US$ Mn), 2019-2032
5.4.1.13. Turkey Pessary Market by Product, Value (US$ Mn), 2019-2032
5.4.1.14. Turkey Pessary Market by Indication, Value (US$ Mn), 2019-2032
5.4.1.15. Turkey Pessary Market by End User, Value (US$ Mn), 2019-2032
5.4.1.16. Russia Pessary Market by Product, Value (US$ Mn), 2019-2032
5.4.1.17. Russia Pessary Market by Indication, Value (US$ Mn), 2019-2032
5.4.1.18. Russia Pessary Market by End User, Value (US$ Mn), 2019-2032
5.4.1.19. Rest of Europe Pessary Market by Product, Value (US$ Mn), 2019-2032
5.4.1.20. Rest of Europe Pessary Market by Indication, Value (US$ Mn), 2019-2032
5.4.1.21. Rest of Europe Pessary Market by End User, Value (US$ Mn), 2019-2032
5.4.2. BPS Analysis/Market Attractiveness Analysis
6. Asia Pacific Pessary Market Outlook, 2019-2032
6.1. Asia Pacific Pessary Market Outlook, by Product, Value (US$ Mn), 2019-2032
6.1.1. Key Highlights
6.1.1.1. Ring Pessaries
6.1.1.2. Lever Pessaries
6.1.1.3. Incontinence Rings
6.1.1.4. Marland
6.1.1.5. Gellhorn
6.1.1.6. Gehrung
6.1.1.7. Donuts
6.1.1.8. Cubes
6.2. Asia Pacific Pessary Market Outlook, by Indication, Value (US$ Mn), 2019-2032
6.2.1. Key Highlights
6.2.1.1. Pelvic Organ Prolapse
6.2.1.2. Urinary Incontinences
6.3. Asia Pacific Pessary Market Outlook, by End User, Value (US$ Mn), 2019-2032
6.3.1. Key Highlights
6.3.1.1. Hospitals
6.3.1.2. Ambulatory Surgical Centres
6.3.1.3. Speciality Clinics
6.3.2. BPS Analysis/Market Attractiveness Analysis
6.4. Asia Pacific Pessary Market Outlook, by Country, Value (US$ Mn), 2019-2032
6.4.1. Key Highlights
6.4.1.1. China Pessary Market by Product, Value (US$ Mn), 2019-2032
6.4.1.2. China Pessary Market by Indication, Value (US$ Mn), 2019-2032
6.4.1.3. China Pessary Market by End User, Value (US$ Mn), 2019-2032
6.4.1.4. Japan Pessary Market by Product, Value (US$ Mn), 2019-2032
6.4.1.5. Japan Pessary Market by Indication, Value (US$ Mn), 2019-2032
6.4.1.6. Japan Pessary Market by End User, Value (US$ Mn), 2019-2032
6.4.1.7. South Korea Pessary Market by Product, Value (US$ Mn), 2019-2032
6.4.1.8. South Korea Pessary Market by Indication, Value (US$ Mn), 2019-2032
6.4.1.9. South Korea Pessary Market by End User, Value (US$ Mn), 2019-2032
6.4.1.10. India Pessary Market by Product, Value (US$ Mn), 2019-2032
6.4.1.11. India Pessary Market by Indication, Value (US$ Mn), 2019-2032
6.4.1.12. India Pessary Market by End User, Value (US$ Mn), 2019-2032
6.4.1.13. Southeast Asia Pessary Market by Product, Value (US$ Mn), 2019-2032
6.4.1.14. Southeast Asia Pessary Market by Indication, Value (US$ Mn), 2019-2032
6.4.1.15. Southeast Asia Pessary Market by End User, Value (US$ Mn), 2019-2032
6.4.1.16. Rest of Asia Pacific Pessary Market by Product, Value (US$ Mn), 2019-2032
6.4.1.17. Rest of Asia Pacific Pessary Market by Indication, Value (US$ Mn), 2019-2032
6.4.1.18. Rest of Asia Pacific Pessary Market by End User, Value (US$ Mn), 2019-2032
6.4.2. BPS Analysis/Market Attractiveness Analysis
7. Latin America Pessary Market Outlook, 2019-2032
7.1. Latin America Pessary Market Outlook, by Product, Value (US$ Mn), 2019-2032
7.1.1. Key Highlights
7.1.1.1. Ring Pessaries
7.1.1.2. Lever Pessaries
7.1.1.3. Incontinence Rings
7.1.1.4. Marland
7.1.1.5. Gellhorn
7.1.1.6. Gehrung
7.1.1.7. Donuts
7.1.1.8. Cubes
7.2. Latin America Pessary Market Outlook, by Indication, Value (US$ Mn), 2019-2032
7.2.1.1. Pelvic Organ Prolapse
7.2.1.2. Urinary Incontinences
7.3. Latin America Pessary Market Outlook, by End User, Value (US$ Mn), 2019-2032
7.3.1. Key Highlights
7.3.1.1. Hospitals
7.3.1.2. Ambulatory Surgical Centres
7.3.1.3. Speciality Clinics
7.3.2. BPS Analysis/Market Attractiveness Analysis
7.4. Latin America Pessary Market Outlook, by Country, Value (US$ Mn), 2019-2032
7.4.1. Key Highlights
7.4.1.1. Brazil Pessary Market by Product, Value (US$ Mn), 2019-2032
7.4.1.2. Brazil Pessary Market by Indication, Value (US$ Mn), 2019-2032
7.4.1.3. Brazil Pessary Market by End User, Value (US$ Mn), 2019-2032
7.4.1.4. Mexico Pessary Market by Product, Value (US$ Mn), 2019-2032
7.4.1.5. Mexico Pessary Market by Indication, Value (US$ Mn), 2019-2032
7.4.1.6. Mexico Pessary Market by End User, Value (US$ Mn), 2019-2032
7.4.1.7. Argentina Pessary Market by Product, Value (US$ Mn), 2019-2032
7.4.1.8. Argentina Pessary Market by Indication, Value (US$ Mn), 2019-2032
7.4.1.9. Argentina Pessary Market by End User, Value (US$ Mn), 2019-2032
7.4.1.10. Rest of Latin America Pessary Market by Product, Value (US$ Mn), 2019-2032
7.4.1.11. Rest of Latin America Pessary Market by Indication, Value (US$ Mn), 2019-2032
7.4.1.12. Rest of Latin America Pessary Market by End User, Value (US$ Mn), 2019-2032
7.4.2. BPS Analysis/Market Attractiveness Analysis
8. Middle East & Africa Pessary Market Outlook, 2019-2032
8.1. Middle East & Africa Pessary Market Outlook, by Product, Value (US$ Mn), 2019-2032
8.1.1. Key Highlights
8.1.1.1. Ring Pessaries
8.1.1.2. Lever Pessaries
8.1.1.3. Incontinence Rings
8.1.1.4. Marland
8.1.1.5. Gellhorn
8.1.1.6. Gehrung
8.1.1.7. Donuts
8.1.1.8. Cubes
8.2. Middle East & Africa Pessary Market Outlook, by Indication, Value (US$ Mn), 2019-2032
8.2.1. Key Highlights
8.2.1.1. Pelvic Organ Prolapse
8.2.1.2. Urinary Incontinences
8.3. Middle East & Africa Pessary Market Outlook, by End User, Value (US$ Mn), 2019-2032
8.3.1. Key Highlights
8.3.1.1. Hospitals
8.3.1.2. Ambulatory Surgical Centres
8.3.1.3. Speciality Clinics
8.3.2. BPS Analysis/Market Attractiveness Analysis
8.4. Middle East & Africa Pessary Market Outlook, by Country, Value (US$ Mn), 2019-2032
8.4.1. Key Highlights
8.4.1.1. GCC Pessary Market by Product, Value (US$ Mn), 2019-2032
8.4.1.2. GCC Pessary Market by Indication, Value (US$ Mn), 2019-2032
8.4.1.3. GCC Pessary Market by End User, Value (US$ Mn), 2019-2032
8.4.1.4. South Africa Pessary Market by Product, Value (US$ Mn), 2019-2032
8.4.1.5. South Africa Pessary Market by Indication, Value (US$ Mn), 2019-2032
8.4.1.6. South Africa Pessary Market by End User, Value (US$ Mn), 2019-2032
8.4.1.7. Egypt Pessary Market by Product, Value (US$ Mn), 2019-2032
8.4.1.8. Egypt Pessary Market by Indication, Value (US$ Mn), 2019-2032
8.4.1.9. Egypt Pessary Market by End User, Value (US$ Mn), 2019-2032
8.4.1.10. Nigeria Pessary Market by Product, Value (US$ Mn), 2019-2032
8.4.1.11. Nigeria Pessary Market by Indication, Value (US$ Mn), 2019-2032
8.4.1.12. Nigeria Pessary Market by End User, Value (US$ Mn), 2019-2032
8.4.1.13. Rest of Middle East & Africa Pessary Market by Product, Value (US$ Mn), 2019-2032
8.4.1.14. Rest of Middle East & Africa Pessary Market by Indication, Value (US$ Mn), 2019-2032
8.4.1.15. Rest of Middle East & Africa Pessary Market by End User, Value (US$ Mn), 2019-2032
8.4.2. BPS Analysis/Market Attractiveness Analysis
9. Competitive Landscape
9.1. By Distribution Channel vs by Indication Heat map
9.2. Manufacturer vs by Indication Heatmap
9.3. Company Market Share Analysis, 2025
9.4. Competitive Dashboard
9.5. Company Profiles
9.5.1. CooperSurgical Inc.
9.5.1.1. Company Overview
9.5.1.2. Product Portfolio
9.5.1.3. Financial Overview
9.5.1.4. Business Strategies and Development
9.5.2. Bliss GVS Pharma
9.5.2.1. Company Overview
9.5.2.2. Product Portfolio
9.5.2.3. Financial Overview
9.5.2.4. Business Strategies and Development
9.5.3. MedGyn
9.5.3.1. Company Overview
9.5.3.2. Product Portfolio
9.5.3.3. Financial Overview
9.5.3.4. Business Strategies and Development
9.5.4. Panpac Medical Corporation
9.5.4.1. Company Overview
9.5.4.2. Product Portfolio
9.5.4.3. Financial Overview
9.5.4.4. Business Strategies and Development
9.5.5. Personal Medical Corporation
9.5.5.1. Company Overview
9.5.5.2. Product Portfolio
9.5.5.3. Financial Overview
9.5.5.4. Business Strategies and Development
9.5.6. Dr. Arabin GmbH & Co.
9.5.6.1. Company Overview
9.5.6.2. Product Portfolio
9.5.6.3. Financial Overview
9.5.6.4. Business Strategies and Development
9.5.7. Kangge Medical
9.5.7.1. Company Overview
9.5.7.2. Product Portfolio
9.5.7.3. Financial Overview
9.5.7.4. Business Strategies and Development
9.5.8. Integra Lifesciences
9.5.8.1. Company Overview
9.5.8.2. Product Portfolio
9.5.8.3. Financial Overview
9.5.8.4. Business Strategies and Development
9.5.9. Wallach Surgical Devices
9.5.9.1. Company Overview
9.5.9.2. Product Portfolio
9.5.9.3. Financial Overview
9.5.9.4. Business Strategies and Development
9.5.10. Medesign
9.5.10.1. Company Overview
9.5.10.2. Product Portfolio
9.5.10.3. Financial Overview
9.5.10.4. Business Strategies and Development
10. Appendix
10.1. Research Methodology
10.2. Report Assumptions
10.3. Acronyms and Abbreviations

Companies Mentioned

  • CooperSurgical Inc
  • Bliss GVS Pharma
  • MedGyn
  • Panpac Medical Corporation
  • Bioteque America
  • Personal Medical Corporation
  • Dr.Arabin GmbH & Co.
  • Kangge Medical
  • Integra Lifesciences
  • Wallach Surgical Devices
  • Medesign